When quantifying P-AURKA normalized to the total AURKA and then related to the control, we found that phosphorylated AURKA levels were significantly decreased in neurons (NeuN) from postmortem human AD brains compared with the control brain (Figure 2). The gene discussed is RBFOX3; the disease is Alzheimer disease.